Data as of May 17
| -0.12 / -0.27%|
The 8 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 44.25, with a high estimate of 50.00 and a low estimate of 37.00. The median estimate represents a -1.69% decrease from the last price of 45.01.
The current consensus among 16 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.